Italy’s Angelini Pharma has acquired the rights to GlaxoSmithKline PLC’s ThermaCare pain-relief brand in all markets outside North America. According to local media reports, the purchase price was around €190m ($216m).
GSK Divests ThermaCare To Angelini
Italy's Angelini expects its acquisition of the ThermaCare pain-relief line to spur the company's European growth ambitions in the consumer healthcare market.
